Breaking News Instant updates and real-time market news.

HSBC

HSBC

$18.46 /

-1.275 (-6.46%)

10:55
09/21/20
09/21
10:55
09/21/20
10:55

HSBC put volume heavy and directionally bearish

Bearish flow noted in HSBC with 10,452 puts trading, or 9x expected. Most active are Oct-20 17.5 puts and Dec-20 20 puts, with total volume in those strikes near 5,400 contracts. The Put/Call Ratio is 3.18, while ATM IV is up over 6 points on the day. Earnings are expected on October 27th.

HSBC HSBC
$18.46 /

-1.275 (-6.46%)

08/11/20 Morgan Stanley
HSBC upgraded to Equal Weight from Underweight at Morgan Stanley
08/07/20 Berenberg
HSBC price target lowered to 380 GBp from 390 GBp at Berenberg
08/04/20 Credit Suisse
HSBC price target lowered to 330 GBp from 370 GBp at Credit Suisse
08/04/20 Deutsche Bank
HSBC price target lowered to 300 GBp from 335 GBp at Deutsche Bank

TODAY'S FREE FLY STORIES

Hot Stocks
Color Star Technology receives Nasdaq continued listing deficiency notice » 16:30
10/22/20
10/22
16:30
10/22/20
16:30
CSCW

Color Star Technology

$0.55 /

+0.0173 (+3.25%)

Color Star Technology…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CSCW Color Star Technology
$0.55 /

+0.0173 (+3.25%)

Hot Stocks
Sigma Labs announces PrintRite3D for Directed Energy Deposition » 16:30
10/22/20
10/22
16:30
10/22/20
16:30
SGLB

Sigma Labs

$2.90 /

-0.17 (-5.54%)

Sigma Lab announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SGLB Sigma Labs
$2.90 /

-0.17 (-5.54%)

Initiation
CTI BioPharma initiated with a Buy at Brookline » 16:30
10/22/20
10/22
16:30
10/22/20
16:30
CTIC

CTI BioPharma

$3.32 /

+0.06 (+1.84%)

Brookline analyst Leah…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CTIC CTI BioPharma
$3.32 /

+0.06 (+1.84%)

CTIC CTI BioPharma
$3.32 /

+0.06 (+1.84%)

09/30/20 JMP Securities
JMP Securities raises CTI BioPharma target to $4 on accelerated approval pathway
09/30/20 Needham
CTI BioPharma price target raised to $6 from $3.50 at Needham
06/24/20 JMP Securities
CTI BioPharma resumed with an Outperform at JMP Securities
CTIC CTI BioPharma
$3.32 /

+0.06 (+1.84%)

CTIC CTI BioPharma
$3.32 /

+0.06 (+1.84%)

CTIC CTI BioPharma
$3.32 /

+0.06 (+1.84%)

Options
Preliminary option volume of 26.6M today » 16:30
10/22/20
10/22
16:30
10/22/20
16:30

Preliminary option volume…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Earnings
Byline Bancorp reports Q3 EPS 34c, consensus 21c » 16:29
10/22/20
10/22
16:29
10/22/20
16:29
BY

Byline Bancorp

$13.84 /

+0.34 (+2.52%)

Reports Q3 NII $53.5M vs.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BY Byline Bancorp
$13.84 /

+0.34 (+2.52%)

BY Byline Bancorp
$13.84 /

+0.34 (+2.52%)

12/19/19 Stephens
Byline Bancorp upgraded to Overweight from Equal Weight at Stephens
BY Byline Bancorp
$13.84 /

+0.34 (+2.52%)

Earnings
BayCom reports Q3 EPS 27c, consensus 41c » 16:29
10/22/20
10/22
16:29
10/22/20
16:29
BCML

BayCom

$12.49 /

+0.47 (+3.91%)

Annualized net interest…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BCML BayCom
$12.49 /

+0.47 (+3.91%)

BCML BayCom
$12.49 /

+0.47 (+3.91%)

04/27/20 B. Riley FBR
BayCom price target lowered to $15 from $19 at B. Riley FBR
BCML BayCom
$12.49 /

+0.47 (+3.91%)

Downgrade
Wintrust downgraded to Market Perform from Outperform at Keefe Bruyette » 16:28
10/22/20
10/22
16:28
10/22/20
16:28
WTFC

Wintrust Financial

$50.25 /

-0.13 (-0.26%)

Keefe Bruyette analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WTFC Wintrust Financial
$50.25 /

-0.13 (-0.26%)

08:33 Today Wedbush
Wintrust Financial price target raised to $57 from $50 at Wedbush
04/06/20 Raymond James
Wintrust Financial upgraded to Strong Buy from Outperform at Raymond James
04/01/20 Keefe Bruyette
Wintrust Financial upgraded to Outperform from Market Perform at Keefe Bruyette
03/06/20 SunTrust
SunTrust cuts price targets on Banks amid lower interest rate environment
WTFC Wintrust Financial
$50.25 /

-0.13 (-0.26%)

Earnings
Associated Banc-Corp reports Q3 EPS 26c, consensus 20c » 16:28
10/22/20
10/22
16:28
10/22/20
16:28
ASB

Associated Banc-Corp

$14.25 /

+0.475 (+3.45%)

Reports Q3 loan loss…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ASB Associated Banc-Corp
$14.25 /

+0.475 (+3.45%)

ASB Associated Banc-Corp
$14.25 /

+0.475 (+3.45%)

10/08/20 Wells Fargo
Associated Banc-Corp upgraded to Overweight from Equal Weight at Wells Fargo
07/09/20 Jefferies
Associated Banc-Corp downgraded to Hold from Buy at Jefferies
03/30/20 Wells Fargo
Associated Banc-Corp upgraded to Equal Weight from Underweight at Wells Fargo
03/30/20 Wells Fargo
Associated Banc-Corp upgraded to Equal Weight from Underweight at Wells Fargo
ASB Associated Banc-Corp
$14.25 /

+0.475 (+3.45%)

Hot Stocks
Simmons First National resumes stock repurchase program » 16:27
10/22/20
10/22
16:27
10/22/20
16:27
SFNC

Simmons First National

$17.39 /

+0.63 (+3.76%)

Simmons First National…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SFNC Simmons First National
$17.39 /

+0.63 (+3.76%)

10/20/20
Fly Intel: Top five analyst downgrades
10/20/20 DA Davidson
Simmons First National downgraded to Neutral from Buy at DA Davidson
06/17/20 Raymond James
Simmons First National upgraded to Outperform from Market Perform at Raymond James
06/17/20 Raymond James
Simmons First National upgraded to Outperform from Market Perform at Raymond James
SFNC Simmons First National
$17.39 /

+0.63 (+3.76%)

Initiation
Allogene Therapeutics initiated with an Outperform at RBC Capital » 16:26
10/22/20
10/22
16:26
10/22/20
16:26
ALLO

Allogene Therapeutics

$35.28 /

+0.82 (+2.38%)

RBC Capital analyst Luca…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALLO Allogene Therapeutics
$35.28 /

+0.82 (+2.38%)

ALLO Allogene Therapeutics
$35.28 /

+0.82 (+2.38%)

16:23 Today RBC Capital
Crispr Therapeutics initiated with a Sector Perform at RBC Capital
10/21/20 Stifel
Crispr Therapeutics price target raised to $93 from $75 at Stifel
10/15/20 Roth Capital
Allogene's new collaboration may enrich anticancer portfolio, says Roth Capital
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
ALLO Allogene Therapeutics
$35.28 /

+0.82 (+2.38%)

  • 02
    Jun
ALLO Allogene Therapeutics
$35.28 /

+0.82 (+2.38%)

Hot Stocks
eHealth falls 16% to $68.96 after reporting Q3 results  16:25
10/22/20
10/22
16:25
10/22/20
16:25
EHTH

eHealth

$82.01 /

+0.21 (+0.26%)

 
ShowHide Related Items >><<
EHTH eHealth
$82.01 /

+0.21 (+0.26%)

EHTH eHealth
$82.01 /

+0.21 (+0.26%)

10/07/20 Deutsche Bank
eHealth growth unlikely impacted by Walmart entrance, says Deutsche Bank
10/06/20 Credit Suisse
Walmart entry shows attractiveness of insurance market, says Credit Suisse
10/06/20 Citi
Walmart entry a 'significant competitive threat' to eHealth, says Citi
09/25/20 Goldman Sachs
eHealth initiated with a Buy at Goldman Sachs
EHTH eHealth
$82.01 /

+0.21 (+0.26%)

  • 04
    Mar
EHTH eHealth
$82.01 /

+0.21 (+0.26%)

EHTH eHealth
$82.01 /

+0.21 (+0.26%)

EHTH eHealth
$82.01 /

+0.21 (+0.26%)

Syndicate
Milestone Pharmaceuticals $40M Spot Secondary; price range $5.00-$5.25 » 16:25
10/22/20
10/22
16:25
10/22/20
16:25
MIST

Milestone Pharmaceuticals

$6.99 /

+0.18 (+2.64%)

Jefferies and Piper…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MIST Milestone Pharmaceuticals
$6.99 /

+0.18 (+2.64%)

MIST Milestone Pharmaceuticals
$6.99 /

+0.18 (+2.64%)

07/29/20 Oppenheimer
Oppenheimer upgrades Milestone to Outperform on 'best-case' FDA outcome
07/29/20 Oppenheimer
Milestone Pharmaceuticals upgraded to Outperform from Perform at Oppenheimer
07/24/20
Fly Intel: Top five analyst upgrades
07/24/20 Jefferies
Jefferies upgrades Milestone to Buy on 'major' FDA win
MIST Milestone Pharmaceuticals
$6.99 /

+0.18 (+2.64%)

  • 20
    Nov
MIST Milestone Pharmaceuticals
$6.99 /

+0.18 (+2.64%)

MIST Milestone Pharmaceuticals
$6.99 /

+0.18 (+2.64%)

Earnings
Robert Half sees Q4 EPS 55c-75c, consensus 65c » 16:25
10/22/20
10/22
16:25
10/22/20
16:25
RHI

Robert Half

$56.48 /

+1.1298 (+2.04%)

Sees Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RHI Robert Half
$56.48 /

+1.1298 (+2.04%)

RHI Robert Half
$56.48 /

+1.1298 (+2.04%)

07/27/20 SunTrust
Robert Half price target raised to $52 from $40 at SunTrust
05/21/20 Credit Suisse
Robert Half upgraded to Neutral on valuation at Credit Suisse
05/21/20 Credit Suisse
Robert Half upgraded to Neutral from Underperform at Credit Suisse
04/24/20 BMO Capital
Robert Half price target raised to $53 from $45 at BMO Capital
RHI Robert Half
$56.48 /

+1.1298 (+2.04%)

RHI Robert Half
$56.48 /

+1.1298 (+2.04%)

General news
Treasury Market Summary » 16:25
10/22/20
10/22
16:25
10/22/20
16:25

Treasury Market Summary:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Tengasco to host conference call » 16:25
10/22/20
10/22
16:25
10/22/20
16:25
TGC

Tengasco

$1.17 /

-0.32 (-21.48%)

Conference call to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TGC Tengasco
$1.17 /

-0.32 (-21.48%)

Hot Stocks
Stitch Fix adds Neal Mohan to board of directors » 16:24
10/22/20
10/22
16:24
10/22/20
16:24
SFIX

Stitch Fix

$34.79 /

-1.22 (-3.39%)

, GOOG

Alphabet

$1,615.70 /

+22.58 (+1.42%)

, GOOGL

Alphabet Class A

$1,607.28 /

+20.53 (+1.29%)

Stitch Fix announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SFIX Stitch Fix
$34.79 /

-1.22 (-3.39%)

GOOG Alphabet
$1,615.70 /

+22.58 (+1.42%)

GOOGL Alphabet Class A
$1,607.28 /

+20.53 (+1.29%)

SFIX Stitch Fix
$34.79 /

-1.22 (-3.39%)

09/30/20 KeyBanc
Stitch Fix price target raised to $36 from $32 at KeyBanc
09/23/20 Truist
Stitch Fix price target raised to $34 from $28 at Truist
09/23/20 Deutsche Bank
Deutsche bullish on Stitch Fix story despite slower Q1 growth
09/21/20 JPMorgan
Stitch Fix price target raised to $28 from $23 at JPMorgan
GOOG Alphabet
$1,615.70 /

+22.58 (+1.42%)

13:05 Today Jefferies
Jefferies says 71% of Google users would still use search if removed from device
10/21/20 JPMorgan
Alphabet arguments against lawsuit have merits, says JPMorgan
10/21/20 Morgan Stanley
Slack downgraded to Underweight on rising competitive risk at Morgan Stanley
10/20/20 Jefferies
Alphabet price target raised to $1,850 from $1,800 at Jefferies
GOOGL Alphabet Class A
$1,607.28 /

+20.53 (+1.29%)

13:05 Today Jefferies
Jefferies says 71% of Google users would still use search if removed from device
10/21/20 JPMorgan
Alphabet arguments against lawsuit have merits, says JPMorgan
10/21/20 Morgan Stanley
Slack downgraded to Underweight on rising competitive risk at Morgan Stanley
10/20/20 Jefferies
Alphabet price target raised to $1,850 from $1,800 at Jefferies
SFIX Stitch Fix
$34.79 /

-1.22 (-3.39%)

GOOG Alphabet
$1,615.70 /

+22.58 (+1.42%)

GOOGL Alphabet Class A
$1,607.28 /

+20.53 (+1.29%)

SFIX Stitch Fix
$34.79 /

-1.22 (-3.39%)

GOOG Alphabet
$1,615.70 /

+22.58 (+1.42%)

GOOGL Alphabet Class A
$1,607.28 /

+20.53 (+1.29%)

SFIX Stitch Fix
$34.79 /

-1.22 (-3.39%)

GOOG Alphabet
$1,615.70 /

+22.58 (+1.42%)

GOOGL Alphabet Class A
$1,607.28 /

+20.53 (+1.29%)

SFIX Stitch Fix
$34.79 /

-1.22 (-3.39%)

GOOGL Alphabet Class A
$1,607.28 /

+20.53 (+1.29%)

GOOGL Alphabet Class A
$1,607.28 /

+20.53 (+1.29%)

Initiation
uniQure initiated with an Outperform at RBC Capital » 16:24
10/22/20
10/22
16:24
10/22/20
16:24
QURE

uniQure

$41.25 /

+1.73 (+4.38%)

, BMRN

BioMarin

$79.25 /

+1.43 (+1.84%)

RBC Capital analyst Luca…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
QURE uniQure
$41.25 /

+1.73 (+4.38%)

BMRN BioMarin
$79.25 /

+1.43 (+1.84%)

QURE uniQure
$41.25 /

+1.73 (+4.38%)

09/16/20 Baird
uniQure weakness a buying opportunity, says Baird
08/24/20 Raymond James
uniQure initiated with a Strong Buy at Raymond James
08/20/20 Baird
uniQure weakness a buying opportunity, says Baird
08/19/20 Cowen
uniQure not asked for two year bleeding rate data, says Cowen
BMRN BioMarin
$79.25 /

+1.43 (+1.84%)

09/10/20 Truist
BioMarin price target lowered to $125 from $130 at Truist
08/25/20 JPMorgan
Sarepta added to Analyst Focus List, named a Top Idea at JPMorgan
08/20/20 RBC Capital
Sarepta selloff on BioMarin CRL overdone ,says RBC Capital
08/20/20
Fly Intel: Top five analyst downgrades
QURE uniQure
$41.25 /

+1.73 (+4.38%)

BMRN BioMarin
$79.25 /

+1.43 (+1.84%)

QURE uniQure
$41.25 /

+1.73 (+4.38%)

QURE uniQure
$41.25 /

+1.73 (+4.38%)

BMRN BioMarin
$79.25 /

+1.43 (+1.84%)

BMRN BioMarin
$79.25 /

+1.43 (+1.84%)

Hot Stocks
Scorpio Bulkers to sell SBI Hyperion for approximately $17.5M » 16:24
10/22/20
10/22
16:24
10/22/20
16:24
SALT

Scorpio Bulkers

$14.12 /

-0.61 (-4.14%)

Scorpio Bulkers announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SALT Scorpio Bulkers
$14.12 /

-0.61 (-4.14%)

SALT Scorpio Bulkers
$14.12 /

-0.61 (-4.14%)

07/07/20 B. Riley FBR
Scorpio Bulkers price target lowered to $35 from $40 at B. Riley FBR
06/10/20 Stifel
Scorpio Bulkers price target lowered to $33 from $40 at Stifel
06/10/20 Jefferies
Scorpio Bulkers downgraded to Hold after equity offering at Jefferies
06/10/20 Jefferies
Scorpio Bulkers downgraded to Hold from Buy at Jefferies
SALT Scorpio Bulkers
$14.12 /

-0.61 (-4.14%)

  • 10
    Jun
SALT Scorpio Bulkers
$14.12 /

-0.61 (-4.14%)

Earnings
CapStar Financial reports Q3 EPS 43c, consensus 28c » 16:24
10/22/20
10/22
16:24
10/22/20
16:24
CSTR

CapStar Financial

$10.89 /

+0.21 (+1.97%)

Operating annualized…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CSTR CapStar Financial
$10.89 /

+0.21 (+1.97%)

CSTR CapStar Financial
$10.89 /

+0.21 (+1.97%)

Initiation
Crispr Therapeutics initiated with a Sector Perform at RBC Capital » 16:23
10/22/20
10/22
16:23
10/22/20
16:23
CRSP

Crispr Therapeutics

$90.22 /

-2.03 (-2.20%)

, BLUE

Bluebird Bio

$55.51 /

+1.29 (+2.38%)

, ALLO

Allogene Therapeutics

$35.28 /

+0.82 (+2.38%)

RBC Capital analyst Luca…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CRSP Crispr Therapeutics
$90.22 /

-2.03 (-2.20%)

BLUE Bluebird Bio
$55.51 /

+1.29 (+2.38%)

ALLO Allogene Therapeutics
$35.28 /

+0.82 (+2.38%)

CRSP Crispr Therapeutics
$90.22 /

-2.03 (-2.20%)

08:00 Today Chardan
Crispr Therapeutics price target raised to $110 from $100 at Chardan
07:25 Today Canaccord
Crispr Therapeutics price target raised to $120 from $110 at Canaccord
06:27 Today Citi
Crispr Therapeutics price target raised to $47 from $31 at Citi
10/21/20 Raymond James
First CAR-T data for Crispr's CTX110 'not good,' says Raymond James
BLUE Bluebird Bio
$55.51 /

+1.29 (+2.38%)

10/20/20 Mizuho
Mizuho starts Bluebird Bio with Buy rating, $123 price target
10/19/20 Mizuho
Bluebird Bio initiated with a Buy at Mizuho
09/22/20 Oppenheimer
Bluebird Bio review timeline consistent with expectations, says Oppenheimer
08/06/20 Wedbush
Bluebird Bio price target lowered to $81 from $89 at Wedbush
ALLO Allogene Therapeutics
$35.28 /

+0.82 (+2.38%)

10/21/20 Stifel
Crispr Therapeutics price target raised to $93 from $75 at Stifel
10/15/20 Roth Capital
Allogene's new collaboration may enrich anticancer portfolio, says Roth Capital
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
06/08/20 SunTrust
Allogene Therapeutics price target raised to $50 from $32 at SunTrust
CRSP Crispr Therapeutics
$90.22 /

-2.03 (-2.20%)

BLUE Bluebird Bio
$55.51 /

+1.29 (+2.38%)

ALLO Allogene Therapeutics
$35.28 /

+0.82 (+2.38%)

  • 01
    Jul
  • 02
    Jun
  • 19
    May
  • 21
    Nov
CRSP Crispr Therapeutics
$90.22 /

-2.03 (-2.20%)

BLUE Bluebird Bio
$55.51 /

+1.29 (+2.38%)

ALLO Allogene Therapeutics
$35.28 /

+0.82 (+2.38%)

Earnings
Boston Beer raises 2020 non-GAAP EPS view to $14.00-$15.00 from $11.70-$12.70 » 16:23
10/22/20
10/22
16:23
10/22/20
16:23
SAM

Boston Beer

$918.98 /

+6.49 (+0.71%)

Consensus for 2020 EPS is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SAM Boston Beer
$918.98 /

+6.49 (+0.71%)

SAM Boston Beer
$918.98 /

+6.49 (+0.71%)

10/15/20 Deutsche Bank
Boston Beer price target raised to $835 from $656 at Deutsche Bank
09/03/20 MKM Partners
Boston Beer price target raised to $780 from $353 at MKM Partners
09/02/20 Citi
Boston Beer price target raised to $1,015 from $815 at Citi
08/27/20 Guggenheim
Boston Beer price target raised to $977 from $822 at Guggenheim
SAM Boston Beer
$918.98 /

+6.49 (+0.71%)

SAM Boston Beer
$918.98 /

+6.49 (+0.71%)

Earnings
Shore Bancshares reports Q3 EPS 27c, consensus 18c » 16:22
10/22/20
10/22
16:22
10/22/20
16:22
SHBI

Shore Bancshares

$11.85 /

+0.45 (+3.95%)

The company's net…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SHBI Shore Bancshares
$11.85 /

+0.45 (+3.95%)

SHBI Shore Bancshares
$11.85 /

+0.45 (+3.95%)

Hot Stocks
South Plains Financial increases quarterly cash dividend to 5c per share » 16:21
10/22/20
10/22
16:21
10/22/20
16:21
SPFI

South Plains Financial

$14.90 /

+0.28 (+1.92%)

South Plains Financial,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
Initiation
MeiraGTx initiated with an Outperform at RBC Capital » 16:21
10/22/20
10/22
16:21
10/22/20
16:21
MGTX

MeiraGTx

$13.06 /

+0.41 (+3.24%)

RBC Capital analyst Luca…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MGTX MeiraGTx
$13.06 /

+0.41 (+3.24%)

MGTX MeiraGTx
$13.06 /

+0.41 (+3.24%)

10/05/20 Piper Sandler
MeiraGTx data at least as good as competitors, says Piper Sandler
09/15/20 BofA
MeiraGTx reinstated with a Buy at BofA
09/10/20 SMBC Nikko
MeiraGTx initiated with an Outperform at SMBC Nikko
08/06/20 Piper Sandler
Piper says MeiraGTx gets 'very little' credit for 'nicely progressing' programs
MGTX MeiraGTx
$13.06 /

+0.41 (+3.24%)

Hot Stocks
VeriSign ended Q3 w/ 163.7M domain name registrations » 16:21
10/22/20
10/22
16:21
10/22/20
16:21
VRSN

VeriSign

$207.96 /

+2.22 (+1.08%)

The company states:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VRSN VeriSign
$207.96 /

+2.22 (+1.08%)

VRSN VeriSign
$207.96 /

+2.22 (+1.08%)

04/24/20 Baird
VeriSign price target raised to $250 from $220 at Baird
VRSN VeriSign
$207.96 /

+2.22 (+1.08%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.